Expression of different phosphodiesterase genes in human cavernous smooth muscle.
about
Exploring scientifically proven herbal aphrodisiacsCurrent and future trends in the oral pharmacotherapy of male erectile dysfunction.Erectile dysfunction: expectations beyond phosphodiesterase type 5 inhibition.Mechanisms of action of PDE5 inhibition in erectile dysfunction.Isolation and characterization of smooth muscle cells from rat corpus cavernosum tissue for the study of erectile dysfunctionUnderstanding and targeting the Rho kinase pathway in erectile dysfunction.The future of the oral pharmacotherapy of male erectile dysfunction: things to come.Tadalafil: in the treatment of signs and symptoms of benign prostatic hyperplasia with or without erectile dysfunction.Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations.Pharmacotherapeutic management of erectile dysfunction.Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.Isolation of two isoforms of phosphodiesterase 5 from rat penis.Phosphodiesterase-9 (PDE9) inhibition with BAY 73-6691 increases corpus cavernosum relaxations mediated by nitric oxide-cyclic GMP pathway in mice.Role of PDE9 in Cognition.Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with erectile dysfunction and coronary artery disease.
P2860
Q34655086-9C9D4E98-EDF6-4C68-BFE4-768FD951B088Q35207625-5811CD16-9C7E-43B8-9668-C4C91FCC9E45Q35765882-29EE3C13-93CB-4B6E-B406-27B1EB212883Q35821251-DE45BCA7-8D29-49B1-87C3-89CBF6EC1E8BQ36189774-512A9361-DE81-4422-8C1A-2FC8464BA2DAQ36416633-F9A58AC4-0C1A-4E74-9662-218C430DF16DQ36866594-ECC67602-3F05-4113-BE0E-086B29269F83Q38047228-787C9845-D2A2-4D2B-805B-935B2F94FBB1Q38222740-82C5E95B-99B7-4262-A9D1-FCD246E30BCEQ38583391-3968C36D-E409-4A8F-AB27-C1F17E22FCE4Q41585040-13C1E0B4-DADF-4CD2-B1E5-671C299E5635Q44467347-7F5E641A-FFA2-43B3-BBBE-8CE5CD6D262CQ45904083-B1CB0D5E-0532-44EF-AB40-391451679168Q46299650-C98C8161-38D7-4356-86E6-D45024B7A4D5Q50682697-DD54B84B-11A0-4359-AA1F-E204C62176BA
P2860
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@ast
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@en
type
label
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@ast
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@en
prefLabel
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@ast
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@en
P2093
P1476
Expression of different phosphodiesterase genes in human cavernous smooth muscle.
@en
P2093
Forssmann WG
Wiedenroth A
P304
P356
10.1097/00005392-200101000-00079
P407
P577
2001-01-01T00:00:00Z